HRMY

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · derivative · entry 15

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 25,446 shares

Expires 2034-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · derivative · entry 14

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,594

Underlying: Common Stock · 10,406 shares

Expires 2034-01-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · nonDerivative · entry 9

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,115

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · nonDerivative · entry 8

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 48,967

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · nonDerivative · entry 7

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 23,521

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · derivative · entry 13

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,946

Underlying: Common Stock · 400 shares

Expires 2034-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · derivative · entry 12

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,000

Underlying: Common Stock · 400 shares

Expires 2034-01-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · nonDerivative · entry 6

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,115

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · nonDerivative · entry 5

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,915

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · nonDerivative · entry 4

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,515

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · derivative · entry 11

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 63,346

Underlying: Common Stock · 900 shares

Expires 2034-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · derivative · entry 10

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 29,400

Underlying: Common Stock · 900 shares

Expires 2034-01-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · nonDerivative · entry 3

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,115

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.03. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · nonDerivative · entry 2

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,915

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0002009762-26-000006 · form4-09182026_080908.xml · nonDerivative · entry 1

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,015

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0002009762-26-000005 · form4-09092026_090911.xml · derivative · entry 8

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,246

Underlying: Common Stock · 10,754 shares

Expires 2034-05-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on May 1, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0002009762-26-000005 · form4-09092026_090911.xml · derivative · entry 7

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 30,300

Underlying: Common Stock · 12,200 shares

Expires 2034-01-24

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on January 24, 2025, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date

SEC source: 0002009762-26-000005 · form4-09092026_090911.xml · nonDerivative · entry 6

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,115

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.00 to $43.20. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0002009762-26-000005 · form4-09092026_090911.xml · nonDerivative · entry 5

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 36,069

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0002009762-26-000005 · form4-09092026_090911.xml · nonDerivative · entry 4

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,315

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0002009762-26-000005 · form4-09092026_090911.xml · nonDerivative · entry 3

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,115

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.59 to $43.02. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0002009762-26-000005 · form4-09092026_090911.xml · nonDerivative · entry 2

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,115

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.59 to $42.57. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0002009762-26-000005 · form4-09092026_090911.xml · nonDerivative · entry 1

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 18,615

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.51 to $42.32. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

SEC source: 0002063957-26-000001 · form4-05182026_080551.xml · derivative · entry 1

Philip Ron M · CIK 0002063957 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,872

Underlying: Common Stock · 21,872 shares

Expires 2036-05-14

F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001494757-26-000002 · form4-05182026_080559.xml · derivative · entry 1

Graf R. Mark · CIK 0001494757 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,872

Underlying: Common Stock · 21,872 shares

Expires 2036-05-14

F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001424383-26-000003 · form4-05192026_010535.xml · derivative · entry 1

Germano Geno J · CIK 0001424383 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,231

Underlying: Common Stock · 21,231 shares

Expires 2036-05-14

F1 · derivative.exercise_date: The stock option shall vest in 36 equal monthly installments beginning on June 14, 2026.

SEC source: 0001659085-26-000002 · form4-05182026_080548.xml · derivative · entry 1

Sender Gary · CIK 0001659085 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,872

Underlying: Common Stock · 21,872 shares

Expires 2036-05-14

F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001739050-26-000001 · form4-05182026_080544.xml · derivative · entry 1

Szyper Linda M · CIK 0001739050 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,872

Underlying: Common Stock · 21,872 shares

Expires 2036-05-14

F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0001821210-26-000002 · form4-05182026_080557.xml · derivative · entry 1

Sabater Juan A. · CIK 0001821210 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,872

Underlying: Common Stock · 21,872 shares

Expires 2036-05-14

F1 · derivative.exercise_date: The stock option shall vest in full on the earlier to occur of (i) May 14, 2027 and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date.

SEC source: 0002009762-26-000004 · form4-05182026_080508.xml · derivative · entry 3

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 37,500

Underlying: Common Stock · 18,750 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F3 · derivative.exercise_date: The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F3 · derivative.expiration_date: The award of restricted stock units was previously granted on May 1, 2024 and shall vest in four equal annual installments beginning on May 1, 2025, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F1 · balance_after: The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock and derivatives beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing.

SEC source: 0002009762-26-000004 · form4-05182026_080508.xml · nonDerivative · entry 2

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,115

F2 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.

SEC source: 0002009762-26-000004 · form4-05182026_080508.xml · nonDerivative · entry 1

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 32,997

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock and derivatives beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing.

SEC source: 0001790218-26-000005 · form4-05182026_080501.xml · derivative · entry 1

Reicin Glenn · CIK 0001790218 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 164,309

Underlying: Common Stock · 164,309 shares

Expires 2036-04-14

F1 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on April 14, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0002064712-26-000004 · form4-04092026_040401.xml · derivative · entry 3

Zaeske Adam H. · CIK 0002064712 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Underlying: Common Stock · 7,500 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F2 · derivative.exercise_date: The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F2 · derivative.expiration_date: The restricted stock units shall vest in four equal annual installments beginning on April 7, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0002064712-26-000004 · form4-04092026_040401.xml · nonDerivative · entry 2

Zaeske Adam H. · CIK 0002064712 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,327

F1 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date

SEC source: 0002064712-26-000004 · form4-04092026_040401.xml · nonDerivative · entry 1

Zaeske Adam H. · CIK 0002064712 · CHIEF COMMERCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,500

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001999888-26-000002 · form4-04062026_080458.xml · derivative · entry 1

Anastasiou Peter · CIK 0001999888 · CHIEF OPERATING OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 212,241

Underlying: Common Stock · 212,241 shares

Expires 2036-04-02

F1 · derivative.exercise_date: The stock option vests with respect to 25% of the underlying shares on April 2, 2027, with the remaining shares vesting ratably on a quarterly basis thereafter until the fourth anniversary of the grant date, subject to the Reporting Person's continued service through each applicable vesting date.

SEC source: 0001579829-26-000003 · form4-04062026_080459.xml · derivative · entry 1

Ignelzi Troy A. · CIK 0001579829 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 17,710

Underlying: Common Stock · 17,710 shares

Expires 2036-04-02

F1 · derivative.exercise_date: The stock option shall vest in 36 equal monthly installments beginning on May 2, 2026.

SEC source: 0001677141-26-000004 · form4-01292026_010123.xml · nonDerivative · entry 1

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: Plan reported

Ownership: Direct

Disclosed balance after: 24,521

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.

F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.57 to $37.70. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: The reporting person's previous Form 4 filed on January 26, 2026 inadvertently misstated the number of shares of common stock beneficially owned following the transactions reported therein, and that the number has been corrected in the current filing.

SEC source: 0002009762-26-000002 · form4-01262026_090132.xml · derivative · entry 8

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,988

Underlying: Common Stock · 2,662 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F5 · derivative.exercise_price: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F5 · derivative.exercise_date: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F5 · derivative.expiration_date: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0002009762-26-000002 · form4-01262026_090132.xml · nonDerivative · entry 4

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,290

F1 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.

SEC source: 0002009762-26-000002 · form4-01262026_090132.xml · nonDerivative · entry 3

Budur Kumar · CIK 0002009762 · CHIEF MEDICAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,662

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001615993-26-000002 · form4-01262026_090130.xml · derivative · entry 8

Dayno Jeffrey M. · CIK 0001615993 · Director · PRESIDENT, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 39,000

Underlying: Common Stock · 13,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F5 · derivative.exercise_price: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F5 · derivative.exercise_date: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F5 · derivative.expiration_date: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0001615993-26-000002 · form4-01262026_090130.xml · nonDerivative · entry 4

Dayno Jeffrey M. · CIK 0001615993 · Director · PRESIDENT, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,346

F1 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.

SEC source: 0001615993-26-000002 · form4-01262026_090130.xml · nonDerivative · entry 3

Dayno Jeffrey M. · CIK 0001615993 · Director · PRESIDENT, CEO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 13,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001677141-26-000002 · form4-01262026_090157.xml · derivative · entry 8

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 14,175

Underlying: Common Stock · 4,725 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F5 · derivative.exercise_price: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F5 · derivative.exercise_date: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F5 · derivative.expiration_date: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0001677141-26-000002 · form4-01262026_090157.xml · nonDerivative · entry 4

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,172

F1 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.

SEC source: 0001677141-26-000002 · form4-01262026_090157.xml · nonDerivative · entry 3

Kapadia Sandip · CIK 0001677141 · CHIEF FINANCIAL OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4,725

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

SEC source: 0001821460-26-000002 · form4-01262026_090155.xml · derivative · entry 8

Serafin Andrew · CIK 0001821460 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7,800

Underlying: Common Stock · 2,600 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · security: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F5 · derivative.exercise_price: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F5 · derivative.exercise_date: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

F5 · derivative.expiration_date: This award of restricted stock units was previously granted on January 25, 2025. The restricted stock units shall vest in four equal annual installments beginning on January 25, 2026, subject to the Reporting Person's continued service through each applicable vesting date. Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock and has no expiration date.

SEC source: 0001821460-26-000002 · form4-01262026_090155.xml · nonDerivative · entry 4

Serafin Andrew · CIK 0001821460 · CHIEF STRATEGY OFFICER

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1,474

F1 · security: Shares withheld by the Issuer to satisfy required income tax withholdings pursuant to the vesting of restricted stock units on their scheduled vesting date.